Roche claims pharma’s largest GPU footprint at NVIDIA’s flagship GTC event
In May 2024, Recursion Pharmaceuticals unveiled BioHive-2, a 504-GPU supercomputer it called the largest in the pharmaceutical industry.…
Roche-backed Chugai taps into longevity field with Pfizer-allied Gero
Japanese drugmaker Chugai is wading into the aging-related disease landscape, an area of drug R&D that’s gaining more…
Wafaa Mamilli To Join Roche As Chief Digital Technology Officer
Headquarters of the Swiss multinational healthcare company Roche in Basel, Switzerland getty Roche, the world’s largest biotechnology company…
Roche speeds up drug development and doubles down on Nvidia – Matthew Griffin
Matthew Griffin is a multi-award winning Futurist and expert in Disruption and Innovation, Geopolitics, Leadership, and Technology, who…
Roche bets splits in obesity market will open door to new entrants
Lilly and Novo Nordisk dominate the market, but Roche’s history in the field dates back decades. In the…
Roche’s prized breast cancer pill fails closely watched study
This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free…
FDA clears Roche, Lilly Alzheimer’s blood test
A blood test developed by Roche and Eli Lilly that could help diagnose patients with Alzheimer’s disease more…
Roche, Lilly’s blood test for Alzheimer’s diagnosis gets US approval
(Reuters) -Roche Diagnostics said on Monday the U.S. Food and Drug Administration cleared its and partner Eli Lilly’s…
Lilly raises stakes in Novartis battle with Verzenio data
Armed with new survival data from the monarchE trial of CDK4/6 inhibitor Verzenio, Eli Lilly looks set to…
Roche signs $5.3 billion deal with Danish obesity drugmaker, Novo Nordisk stock slides 4%
Roche (RHHBY) is increasing its investment into the obesity space with an up to $5.3 billion deal with…
Roche Commits $50B to U.S. Manufacturing, R&D as Tariffs Loom
With tariffs looming over biopharma, Roche became the latest industry giant to announce large-scale plans for new U.S.…
Global Gene Therapy and CRISPR Market Shows Billion Dollar Growth with Novartis Zolgensma 1.2 Billion Sarepta Elevidys 611 Million and Emerging CRISPR Collaborations 20 Million
Precedence Research Precedence Research, a leading strategic research firm, today released a comprehensive overview of the gene therapy…